
CYRISMA: A user-friendly cybersecurity platform for effective risk management.
Founded with the mission to simplify and enhance cybersecurity risk management, CYRISMA offers a comprehensive platform designed to help organizations manage risk efficiently. The company's vision is to provide user-friendly tools that eliminate the complexities typically associated with enterprise cybersecurity solutions. CYRISMA's suite of services includes sensitive data discovery, vulnerability management, secure baseline establishment, dark web monitoring, risk monetization, and mitigation. Their market focus spans resellers and managed service providers, aiming to support a wide range of businesses in achieving robust cybersecurity compliance.
Notable figures affiliated with CYRISMA include key partners and investors who have significantly contributed to its development and market reach. The platform has achieved recognition for its innovative approach to cybersecurity, evidenced by positive case studies and white papers. CYRISMA's impact is reflected in its ability to streamline risk assessment and reporting, providing organizations with actionable insights and enhanced security postures. Through its effective solutions, CYRISMA continues to make substantial contributions to the field of cybersecurity.

Cyera
cyera.com

SecurityStudio
securitystudio.com

CyberSaint
cybersaint.io

Cyturus Technologies
cyturus.com

CyCognito
cycognito.com

Cyvatar.ai
cyvatar.ai

Censys
censys.io

Centraleyes
centraleyes.com

FortifyData
fortifydata.com

cyberconIQ
cyberconiq.com

Cypherleak
cypherleak.com

Cybershield Security

Sikernes Risk Management

Venseca
venseca.com

Carbide
carbidesecure.com
Companies similar to Cyrisma include Cyera, SecurityStudio, CyberSaint and Cyturus Technologies.
Cyrisma was founded in 2018.
Cyrisma's headquarters is located in Rochester, NY, US.
Cyrisma's most recent funding round was for $1.6M (USD) in June 2022.
As of Jun 30, 2022, Cyrisma has raised a total of $1.8M (USD).
Cyrisma has 12 employees as of Feb 4, 2024.